`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`TEVA PHARMACEUTICALS
`INTERNATIONAL GMBH and
`TEVA PHARMACEUTICALS
`USA, INC.,
`
`Plaintiffs,
`
`
`v.
`
`ELI LILLY AND COMPANY,
`Defendant.
`
`
`
`
`
`Civil Action No.
`1:18-cv-12029-ADB
`
`
`ASSENTED TO MOTION FOR LEAVE TO IMPOUND
`CONFIDENTIAL PORTIONS OF PLAINTIFFS’ OPPOSITIONS TO DEFENDANT ELI
`LILLY’S MOTIONS FOR SUMMARY JUDGMENT AND DAUBERT MOTIONS
`
`
`
`Pursuant to Local Rule 7.2(d) and the Protective Order (ECF No. 58), Plaintiffs Teva
`
`Pharmaceuticals International GmbH and Teva Pharmaceuticals USA, Inc. (together, “Plaintiffs”
`
`or “Teva”) hereby move this Court for an Order to impound or otherwise seal the following
`
`documents related to Plaintiffs’ Oppositions to Defendant Eli Lilly and Company’s Motions for
`
`Summary Judgment and Daubert Motions, on the grounds that these documents contain or reveal
`
`the designated confidential and/or proprietary information of Plaintiffs and Defendant Eli Lilly
`
`and Company. Specifically, the documents to be sealed are Plaintiffs’ Memoranda in Opposition,
`
`Declarations, and Exhibits. Plaintiffs will coordinate with Defendant to promptly prepare and file
`
`redacted versions of Plaintiffs’ documents on the public ECF system. The list of documents to be
`
`sealed is as follows:
`
`1.
`Plaintiffs’ Opposition to Defendant Eli Lilly and Company’s Daubert Motion to
`Partially Exclude Testimony of Dr. Elan Rubinstein and Dr. Mark Berkman;
`
`2.
`Exhibits to be attached to the Declaration of Elaine Herrmann Blais in Support of
`Plaintiffs’ Opposition to Eli Lilly and Company’s Daubert Motion to Partially Exclude Testimony
`of Dr. Elan Rubinstein and Dr. Mark Berkman;
`
`
`
`1
`
`
`
`Case 1:18-cv-12029-ADB Document 338 Filed 05/05/22 Page 2 of 5
`
`3.
`Plaintiffs’ Opposition to Eli Lilly and Company’s Motion for Summary Judgment
`of Invalidity for Lack of Written Description;
`
`4.
`L.R. 56.1 Responsive Statement of Material Facts in support of Plaintiffs’
`Opposition to Defendant’s Motion for Summary Judgment for Lack of Written Description;
`
`5.
`Plaintiffs’ Opposition to Eli Lilly and Company’s Motion for Summary Judgment
`of Invalidity for Lack of Enablement;
`
`6.
`L.R. 56.1 Responsive Statement of Material Facts in support of Plaintiffs’
`Opposition to Defendant’s Motion for Summary Judgment for Lack of Enablement;
`
`7.
`Plaintiffs’ Opposition to Defendant’s Motion for Partial Summary Judgment of No
`Willful Infringement;
`
`8.
`L.R. 56.1 Responsive Statement of Material Facts in support of Plaintiffs’
`Opposition to Defendant’s Motion for Summary Judgment of No Willful Infringement;
`
`9.
`Plaintiffs’ Opposition to Defendant’s Motion For Partial Summary Judgment Of
`Non-Infringement;
`
`10.
`L.R. 56.1 Responsive Statement of Material Facts in support of Plaintiffs’
`Opposition to Defendant’s Motion for Summary Judgment of Non-Infringement;
`
`11.
`Exhibits to be attached to the Declaration of Elaine Herrmann Blais in Support of
`Plaintiffs’ Oppositions to Eli Lilly and Company’s Motions for Summary Judgment;
`
`12.
`Declaration of Yasmina Abdiche, Ph.D. in Support of Teva’s Oppositions to Lilly’s
`Motions for Summary Judgment of Invalidity for (1) Lack of Enablement, and (2) Lack of Written
`Description; and
`
`13.
`
`Declaration of Jeffrey V. Ravetch, M.D., Ph.D. and Exhibit A thereto.
`
`Plaintiffs propose that the Order sealing Plaintiffs’ Memoranda in Opposition,
`
`Declarations, and Exhibits described above be lifted only in the instance of a further order of the
`
`Court, and that the sealed documents be kept in the clerk’s nonpublic information file during any
`
`post-impoundment period.
`
`WHEREFORE, Plaintiffs respectfully request that this Court allow this Motion.
`
`
`
`
`
`
`
`2
`
`
`
`Case 1:18-cv-12029-ADB Document 338 Filed 05/05/22 Page 3 of 5
`
`Dated: May 5, 2022
`
`Respectfully Submitted,
`
`/s/ Elaine Herrmann Blais
`Douglas J. Kline (BBO# 556680)
`Elaine Herrmann Blais (BBO# 656142)
`Robert Frederickson III (BBO# 670111)
`Joshua S. Weinger (BBO# 690814)
`Alexandra Lu (BBO# 691114)
`Eric T. Romeo (BBO# 691591)
`Kathleen A. McGuinness (BBO# 693760)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`dkline@goodwinlaw.com
`eblais@goodwinlaw.com
`rfrederickson@goodwinlaw.com
`jweinger@goodwinlaw.com
`alu@goodwinlaw.com
`eromeo@goodwinlaw.com
`kmcguinness@goodwinlaw.com
`
`I. Neel Chatterjee (pro hac vice)
`GOODWIN PROCTER LLP
`601 Marshall St.
`Redwood City, CA 94063
`Tel.: (650) 752-3100
`Fax: (650) 853-1038
`nchatterjee@goodwinlaw.com
`
`Natasha E. Daughtrey (pro hac vice)
`Sean M. Anderson (pro hac vice)
`GOODWIN PROCTER LLP
`601 S. Figueroa St.
`Los Angeles, CA 90017
`Tel.: (213) 426-2500
`Fax: (213) 623-1673
`ndaughtrey@goodwinlaw.com
`sanderson@goodwinlaw.com
`
`
`
`
`
`
`3
`
`
`
`Case 1:18-cv-12029-ADB Document 338 Filed 05/05/22 Page 4 of 5
`
`Madeline R. DiLascia (pro hac vice)
`GOODWIN PROCTER LLP
`1900 N Street N.W.
`Washington, D.C. 20036
`Tel.: (202) 346-4000
`Fax.: (202) 204-7250
`mdilascia@goodwinlaw.com
`
`Attorneys for Plaintiffs
`
`
`
`
`
`
`
`4
`
`
`
`Case 1:18-cv-12029-ADB Document 338 Filed 05/05/22 Page 5 of 5
`
`
`
`LR 7.1(a)(2) CERTIFICATION
`
`I, Elaine Herrmann Blais, hereby certify that Plaintiffs’ counsel conferred with Defendant’s
`
`counsel regarding this motion and that Defendant’s counsel indicated that Defendant assents to
`
`this motion.
`
`
`
`
`
`/s/ Elaine Herrmann Blais
`Elaine Herrmann Blais
`
`CERTIFICATE OF SERVICE
`
`I, Elaine Hermann Blais, hereby certify that this document filed through the ECF system
`
`will be sent electronically to the registered participants as identified on the Notice of Electronic
`
`Filing (“NEF”) and paper copies will be sent to those indicated as non-registered participants on
`
`May 5, 2022.
`
`
`
`/s/ Elaine Herrmann Blais
`Elaine Herrmann Blais (BBO# 656142)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel.: (617) 570-1000
`Fax: (617) 523-1231
`eblais@goodwinlaw.com
`
`
`
`
`
`5
`
`